Precirix - Crunchbase Company Profile & Funding

Q: Who invested in Precirix?

Precirix has 9 investors including Pontifax And Inkef.

Q: When was the last funding round for Precirix?

Precirix closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Precirix raised to date?

Precirix has raised obfuscated.

Overview

Precirix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Precirix

CB Rank

67130

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Founded

obfuscation

Private

Series B

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

11-50

www.precirix.com

Biotechnology

Health Care

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Matthias D'Huyvetter: Co Founder & Science Director
Ruth Devenyns: CEO
Past Role: Biovia, Director

Details

Legal Name

Precirix NV

Operating Status

Active

Company Type

For Profit

Founders

Geert Raes, Jens De Vos, Ludwig Camusot, Matthias D'Huyvetter, Nick Devoogdt

About the Company

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CAM-FAP-Ac-225

A targeted alpha therapy radiopharmaceutical designed to treat tumors expressing Fibroblast Activation Protein (FAP).

CAM-H2

A HER2-directed radiopharmaceutical for treating HER2-positive breast cancer, including brain metastases.

Research & Development

Precirix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B
obfuscated obfuscation	Series B - Precirix	9	obfuscated obfuscation	Forbion Capital Partners, Inkef, Jeito Capital	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Pontifax	—	Series B - Precirix	Ohad Hammer
Pontifax	—	Series B - Precirix	Ohad Hammer
Pontifax	—	Series B - Precirix	Ohad Hammer
Pontifax	—	Series B - Precirix	Ohad Hammer
Pontifax	—	Series B - Precirix	Ohad Hammer